<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: cellular proliferation</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Scientists find potential therapeutic target for Cushing's disease</title>
   	 <description>Scientists at the Salk Institute for Biological Studies have identified a protein that drives the formation of pituitary tumors in Cushing's disease, a development that may give clinicians a therapeutic target to treat this potentially life-threatening disorder.</description>
     <link>http://medicalxpress.com/news/2013-05-scientists-potential-therapeutic-cushing-disease.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 07 May 2013 16:11:18 EST</pubDate>
	 <guid isPermaLink="false">news287161860</guid>
	 
</item>
<item>
     <title>From protein signaling to cancer drug development</title>
   	 <description>(Medical Xpress)—Living organ­isms depend on pro­teins for their sur­vival. These large, com­plex mol­e­cules mediate nearly every life func­tion, but when the genes that code for them start to mutate, those func­tions begin to break down.</description>
     <link>http://medicalxpress.com/news/2013-01-protein-cancer-drug.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 08 Jan 2013 06:35:08 EST</pubDate>
	 <guid isPermaLink="false">news276849299</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/fromproteins.jpg" width="90" height="90" />
</item>
<item>
     <title>Improving the development of new cancer models using an advanced biomedical imaging method</title>
   	 <description>Scientists at the University of Arizona Cancer Center and the Moffitt Cancer Center, led by Dr. Robert Gillies, have demonstrated that an advanced magnetic resonance imaging (MRI) method can non-invasively evaluate the cellular proliferation of tumor models of breast cancer. This quantitative imaging method evaluates the diffusion of water in tumor tissue, which correlates with the growth rates of the tumor models. The results, which appear in the November 2012 issue of Experimental Biology and Medicine, can contribute to the development of new tumor models for cancer research.</description>
     <link>http://medicalxpress.com/news/2012-12-cancer-advanced-biomedical-imaging-method.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 17 Dec 2012 12:34:16 EST</pubDate>
	 <guid isPermaLink="false">news274970050</guid>
	 
</item>
<item>
     <title>PET imaging used to more accurately manage treatment, predict survival for patients with gliomas</title>
   	 <description>In the management of gliomas—or tumors that originate in the brain—precise assessment of tumor grade and the proliferative activity of cells plays a major role in determining the most appropriate treatment and predicting overall survival. Research published in the December issue of The Journal of Nuclear Medicine (JNM) highlights the potential of imaging with 3'-deoxy-3'-F-18-fluorothymidine (F-18-FLT) positron emission tomography (PET) to noninvasively and accurately provide tumor-specific details to guide management of patients with gliomas.</description>
     <link>http://medicalxpress.com/news/2012-12-pet-imaging-accurately-treatment-survival.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 03 Dec 2012 13:05:45 EST</pubDate>
	 <guid isPermaLink="false">news273762333</guid>
	 
</item>
<item>
     <title>Research could lead to new ways to ID women who have higher risk of breast cancer from low-dose radiation</title>
   	 <description>(Medical Xpress)—Scientists from the U.S. Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab) have identified tissue mechanisms that may influence a woman's susceptibility or resistance to breast cancer after exposure to low-dose ionizing radiation, such as the levels used in full-body CT scans and radiotherapy.</description>
     <link>http://medicalxpress.com/news/2012-10-ways-id-women-higher-breast.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 16 Oct 2012 06:45:32 EST</pubDate>
	 <guid isPermaLink="false">news269588720</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/3-researchcoul.jpg" width="90" height="90" />
</item>
<item>
     <title>Solving puzzle of B-cell lymphoma development</title>
   	 <description>Germinal centers are sites in the organs of the lymphatic system, formed during the course of an immune response to infection, where B cells intensely proliferate and modify their DNA in order to produce antibodies specific for the pathogen. However, it is known that the vast majority of lymphomas derive from the B cells at the germinal centers. </description>
     <link>http://medicalxpress.com/news/2012-09-puzzle-b-cell-lymphoma.html</link>
	 <category>Immunology</category>
	 <pubDate>Sun, 23 Sep 2012 13:00:08 EST</pubDate>
	 <guid isPermaLink="false">news267602068</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/wetert45.jpg" width="90" height="90" />
</item>
<item>
     <title>Clusters of cooperating tumor-suppressor genes are found in large regions deleted in common cancers</title>
   	 <description>Scientists at Cold Spring Harbor Laboratory (CSHL) and Memorial Sloan-Kettering Cancer Center have amassed strong experimental evidence implying that commonly occurring large chromosomal deletions that are seen in many cancer types contain areas harboring multiple functionally linked genes whose loss, they posit, confers a survival advantage on growing tumors.</description>
     <link>http://medicalxpress.com/news/2012-05-clusters-cooperating-tumor-suppressor-genes-large.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 07 May 2012 15:00:12 EST</pubDate>
	 <guid isPermaLink="false">news255613710</guid>
	 
</item>
<item>
     <title>Celecoxib may prevent lung cancer in former smokers</title>
   	 <description>Celecoxib may emerge as a potent chemopreventive agent for lung cancer, according to a recent study in Cancer Prevention Research, a journal of the American Association for Cancer Research.</description>
     <link>http://medicalxpress.com/news/2011-07-celecoxib-lung-cancer-smokers.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 06 Jul 2011 03:11:22 EST</pubDate>
	 <guid isPermaLink="false">news229140652</guid>
	 
</item>
<item>
     <title>Researchers demonstrate why DNA breaks down in cancer cells</title>
   	 <description>Damage to normal DNA is a hallmark of cancer cells. Although it had previously been known that damage to normal cells is caused by stress to their DNA replication when cancerous cells invade, the molecular basis for this remained unclear.</description>
     <link>http://medicalxpress.com/news/2011-05-dna-cancer-cells.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 03 May 2011 11:07:15 EST</pubDate>
	 <guid isPermaLink="false">news223639620</guid>
	 
</item>


</channel>
</rss>
